Results 251 to 260 of about 134,239 (340)

Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models. [PDF]

Curr Top Behav Neurosci
Bedillion MF, Moore CF, Weerts EM, Arout CA, Harris HM, Haney M.   +5 more
europepmc   +1 more source

Drug use among people in prison: A global review of epidemiology, harms and interventions

Addiction, EarlyView.
Abstract Background and aims People who use drugs are overrepresented in the criminal justice system. We aimed to provide a broad synthesis of the epidemiology, harms and interventions related to drug use and drug use disorders among incarcerated adults worldwide, and highlight gaps in evidence and practice.
Louis Favril, John Strang, Seena Fazel
wiley   +1 more source

Sleep alterations in substance use disorders: a systematic review and meta-analysis. [PDF]

EClinicalMedicine
Oliva HNP, Paiva Prudente T, Paredes Naveda AM, Monteiro-Junior RS, Potenza MN, Morgan PT, Angarita GA.   +6 more
europepmc   +1 more source

Motivational smoking cessation counselling and community‐based follow‐up after hospitalisation for vascular disease: A randomised controlled trial

Addiction, EarlyView.
Abstract Background and aims Evidence for motivational interviewing for smoking cessation is weak, with limited data on long‐term abstinence rates. This trial aimed to evaluate the effect of in‐hospital motivational interviewing‐based smoking cessation counselling combined with proactive referral to community‐based follow‐up on 6‐ and 12‐month ...
Karin Pleym, Elise Sverre, Harald Weedon‐Fekjær, Mohpal Singh Kahlon, Marie Stugaard, Einar Husebye, Serena Tonstad, Toril Dammen, John Munkhaugen   +8 more
wiley   +1 more source

Editorial: Ultra-processed food addiction: moving toward consensus on mechanisms, definitions, assessment, and intervention. [PDF]

Front Psychiatry
Unwin J, Wiss DA, Soto-Mota A.
europepmc   +1 more source

Secondary analysis of a combined harm‐reduction treatment and extended‐release naltrexone randomized clinical trial for alcohol use disorder: Differences across race, ethnicity and sex assigned at birth

Addiction, EarlyView.
Abstract Background and Aims In a prior randomized clinical trial (RCT), combined pharmacobehavioral harm‐reduction treatment improved alcohol outcomes and physical health‐related quality of life (PH‐QoL). In this secondary analysis, we tested race, ethnicity and sex assigned at birth as predictors and moderators of these effects.
Silvi C. Goldstein, Nicole H. Weiss, Manshu Yang, Sarah W. Feldstein Ewing, Susan E. Collins   +4 more
wiley   +1 more source

Should Elective TIPS be Placed in Non-Abstinent Patients With Alcohol-Related Cirrhosis? [PDF]

United European Gastroenterol J
Rudler M, Thabut D.
europepmc   +1 more source

From Dreamers to Dangerous Women: A Shift from Abstinence and Hypersexuality to Sexuality with Shame in Pop Music Listened to by Tween Girls in 2006 and 2016

, 2017
Jaclyn Griffith
openalex   +1 more source

Behavioral Counseling and Abstinence-Contingent Take-Home Buprenorphine in Malaysia: A Randomized, Open Label Trial

, 2018
Richard S. Schottenfeld, Marek C. Chawarski, Mahmud Mazlan   +2 more
openalex   +1 more source

Exploring the genetic overlap between substance use disorder and educational attainment

Addiction, EarlyView.
Abstract Background and aims Substance use disorder (SUD) is a polygenic psychiatric condition characterized by persistent drug use despite negative consequences. Several studies support that higher cognitive performance and educational attainment (EA) are associated with a reduced risk for SUD.
Judit Cabana‐Domínguez, Laura Vilar‐Ribó, María Soler Artigas, Silvia Alemany, Natalia Llonga, Pau Carabí‐Gassol, Uxue Zubizarreta‐Arruti, Valeria Macias‐Chimborazo, Lara Grau‐López, Constanza Daigre, Elena Ros‐Cucurull, Raúl Felipe Palma‐Alvarez, Germán Ortega‐Hernández, Noèlia Fernàndez‐Castillo, Bru Cormand, Josep Antoni Ramos‐Quiroga, Marta Ribasés   +16 more
wiley   +1 more source